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Activation of purinergic receptors by extracellular ATP (eATP) released from injured cells has been impli-
cated in the pathogenesis of many neuronal disorders. The P2X7 receptor (P2X7R), an ion-selective
purinergic receptor, is associated with microglial activation and paracrine signaling. However, whether
ATP and P2X7R are involved in radiation-induced brain injury (RBI) remains to be determined. Here,
we found that the eATP level was elevated in the cerebrospinal ﬂuid (CSF) of RBI patients and was
associated with the clinical severity of the disorder. In our experimental model, radiation treatment
increased the level of eATP in the supernatant of primary cultures of neurons and glial cells and in the
CSF of irradiated mice. In addition, ATP administration activated microglia, induced the release of the
inﬂammatory mediators such as cyclooxygenase-2, tumor necrosis factor a and interleukin 6, and pro-
moted neuronal apoptosis. Furthermore, blockade of ATP–P2X7R interaction using P2X7 antagonist
Brilliant Blue G or P2X7 knockdown suppressed radiation-induced microglial activation and proliferation
in the hippocampus, and restored the spatial memory of irradiated mice. Finally, we found that the
PI3K/AKT and nuclear factor jB mediated pathways were downstream of ATP–P2X7R signaling in RBI.
Taken together, our results unveiled the critical role of ATP–P2X7R in brain damage in RBI, suggesting
that inhibition of ATP–P2X7R axis might be a potential strategy for the treatment of patients with RBI.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Radiotherapy is the mainstay of therapy for head and neck
cancers, and its curative efﬁcacy is well-established. However,
radiotherapy can also cause injury to the adjacent normal brain
tissue and lead to neurological complications (Dietrich et al.,
2008; Wang et al., 2010). Radiation-induced brain injury (RBI) is
common and severely inﬂuences the quality of life of patients.
Aside from the use of steroids (Genc et al., 2006) or bevacizumab
(Matuschek et al., 2011), which provide protection to a subset of
patients, no other effective treatments for RBI are currentlyavailable. Moreover, steroids have severe side effects (Noone,
2006), with reports showing exacerbation of cerebral radiation
necrosis in certain patients treated with bevacizumab (Jeyaretna
et al., 2011). Therefore, a comprehensive investigation of RBI
pathogenesis is required to identify novel therapeutic targets and
develop a better treatment and prevention for RBI.
In the adult brain, resting microglia are activated and trans-
formed from a ramiﬁed to an amoeboid morphology in response
to injury (Prinz and Priller, 2014). Activated microglia release
various proinﬂammatory mediators, such as cyclooxygenase-2
(COX-2), tumor necrosis factor a (TNF-a), and interleukin 6 (IL-6)
(Choi et al., 2011; Gonzalez-Scarano and Baltuch, 1999), leading
to neuronal injury, impairment of tissue repair and neuronal
degeneration (Hu et al., 2014). Consistently, the release of proin-
ﬂammatory mediators by activated microglia plays a pivotal role
in the underlying pathology of RBI (Chen and Palmer, 2013;
Monje et al., 2003; Yoritsune et al., 2014). However, the trigger
for microglial release of proinﬂammatory mediators in RBI remains
to be elucidated.
88 P. Xu et al. / Brain, Behavior, and Immunity 50 (2015) 87–100Excessive release of eATP following tissue injury can activate
microglia and is implicated in pathological conditions such as
spinal cord and ischemia reperfusion injuries (Cheng et al., 2014;
Fields and Stevens, 2000; Kobayashi et al., 2013). Among the
ATP-sensitive purinergic receptors, the P2X7 receptor (P2X7R) is
expressed abundantly in the central nervous system (CNS) (Lister
et al., 2007), particularly in microglia. The upregulation of P2X7R
expression in activated microglia has been reported in many neu-
ropathological conditions, including amyotrophic lateral sclerosis
(Gandelman et al., 2010), kainate-induced seizures (Engel et al.,
2012), neuropathic pain (Makoto et al., 2012).
The role of ATP-mediated signaling in RBI remains largely
unknown. Speciﬁcally, it is still unknown whether ATP concentra-
tion alters after radiation and if this change could activatemicroglial
P2X7R to amplify the inﬂammatory response and subsequently
result in brain injury. Here we found a positive correlation between
the ATP levels and severity of RBI. To further our understanding, we
investigated the role of P2X7R in ATP-mediated inﬂammatory
responses to brain injury using an in vivo and in vitro irradiation
model based on previous studies (Hwang et al., 2006; Peng et al.,
2014). The results of this study, suggests that ATP–P2X7R signaling
plays a critical role in the pathogenesis of RBI and its inhibition
might be a potential strategy to ameliorate radiation-induced neu-
ronal damage in patients with RBI.2. Materials and methods
2.1. Ethics statement
This study was approved by the Human Research Review Board
of Sun Yat-Sen Memorial Hospital and was performed in accor-
dance with the Declaration of Helsinki. Written informed consent
was obtained from all participants. BALB/c mice (male) were
obtained from the Laboratory Animal Center of Sun-Yet Sen
University. All animal procedures followed the humane care guide-
lines of the Chinese National Institute of Health, and the protocols
were approved by the Committee on Animal Research of Sun
Yat-Sen University.
2.2. Participants
A total of 36 patients (10 females and 26 males) from Sun
Yat-SenMemorial Hospital who were diagnosed as having RBI after
radiotherapy for nasopharyngeal carcinoma were enrolled
between October 2010 and March 2012. Radiographic evidence
to support the diagnosis of RBI without tumor recurrence or metas-
tases was available for all subjects. The diagnosis of RBI was
deﬁned as a lesion of high intensity on T2-weighted images and
as a lesion of enhancement on post-contrast images, as described
in our previous study (Tang et al., 2014). The control group (8
females and 47 males) included ten patients without RBI after
radiotherapy for nasopharyngeal carcinoma and 45 individuals
who underwent check-up but had no CNS diseases. The subjects
in the control group did not show lesions on magnetic resonance
imaging (MRI) scans. The detailed patient characteristics are listed
in Supplementary Table 1. CSF samples were collected from both
case and control group. Control participants were those with com-
plains of limb numbness, dizziness or similar symptoms, but diag-
nosed to be devoid of CNS disorders.
2.3. Evaluation of neurological symptoms and edema volumes on MRI
scans
The pre-treatment medical histories and results of physical
examinations of the subjects were evaluated. Neurological signsand symptoms were assessed using the Late Effects in
Normal Tissues, Subjective, Objective, Management, Analytic
(LENT-SOMA) scales (Routledge et al., 2003). The MRI evaluation
of radiation injury included measurements of the edema volume
on T2-weighted Fluid-Attenuated Inversion Recovery (FLAIR)
images and the necrotic volume on gadolinium-enhanced areas
of T1-weighted images. The radiologist used manual and semiauto-
matic approaches to identify the outline of the edema, and then the
total edema volume was estimated using Volume Viewer 2 soft-
ware (GE, AW Suite 2.0 6.5.1.z). To determine the necrotic volume,
the radiologist deﬁned the gadolinium-enhanced area to identify
the outline of the lesion, and then the area was calculated auto-
matically using Volume Viewer 2. Because the intracranial volume
differs between patients, the edema and necrotic volumes were
normalized using the mid-sagittal cross-sectional intracranial area,
a surrogate measurement of the intracranial volume (Ferguson
et al., 2005; Nandigam et al., 2007). All MRI studies were evaluated
by a radiologist who was blinded to the grouping.
2.4. Reagents
The culture medium materials (Dulbecco’s Modiﬁed Eagle
Medium-F12, B-27 supplement, and fetal bovine serum) were pur-
chased from GIBCO (USA). Trypsin–EDTA, DNase I, L-glutamine,
and gentamycin were purchased from Sigma (USA). Brilliant Blue
G (BBG) and ATP were purchased from Sigma (USA). The following
antibodies were used: rat anti-CD11b (AbD Serotec, UK), rabbit
anti-IBA1 (Wako, Japan), rabbit anti-COX2 (Millipore, USA), mouse
anti-NeuN (Millipore, USA), rabbit anti-tubulin (Millipore, USA),
and rabbit anti-P2X7R (Alomone Labs, Israel). The ﬂuorescent sec-
ondary antibodies labeled with FITC, Alexa-488, Alexa-594 and Cy3
were purchased from Jackson ImmunoResearch Laboratories
(USA). The Fluorescein FragEL DNA Fragmentation Detection
(TUNEL) Kit was purchased from Millipore (USA). The RT-PCR
and quantitative PCR kits were purchased from TaKaRa (Japan).
Enzyme-linked immunoabsorbent assay (ELISA) kits to measure
TNF-a, COX-2, and IL-6 were obtained from Dakewei (China). The
ATPlite 1step kit was purchased from PerkinElmer (Waltham,
USA). The Western blotting reagents and secondary antibodies
were purchased from WeiJia Inc. (China), and the PVDF membrane
was purchased from Millipore (USA). Experimental equipment was
supplied by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen
University.
2.5. Cell culture and irradiation
Primary microglia derived from newborn mice were prepared
from mixed glial cultures using the ‘‘shaking off’’ method, as
described previously (Suzumura et al., 1987). Brieﬂy, pups were
sterilized with 70% ethanol, the brain tissue was placed on ice cold
HBSS. The meninges, cerebellum and brain stem were removed
under a dissection microscope. The remaining tissue was chopped
into small pieces, washed with serum-free DMEM and then
digested with a mix of papain (30 U/ml), Dnase I (200 lg/ml),
EDTA (0.5 mM) and L-cysteine (0.2 mg/ml) for 30 min at 37 C.
The mixture was then spun down; the pellet was carefully sus-
pended in DMEMwith 10% fetal bovine serum and cells transferred
into a T75 ﬂask. After 24 h the medium (DMEM supplemented with
10% fetal bovine serum, 1 mM Na + pyruvate, 100 units/ml peni-
cillin, and 100 lg/ml streptomycin) was changed. The cells were
cultured until rounded, shiny microglial cells started to ﬂoat off
the astrocyte layer. These cells were shaken off, collected, washed
with DMEM for further experiments. The primary cultured neurons
and astrocytes were harvested from the hippocampi of postnatal
day 0 embryonic mice, as reported previously (Wang et al.,
2011). The cells were randomly divided into four groups: control,
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with BBG pre-treatment. Where relevant, the cells were
pre-incubated with BBG (1 lM ﬁnal concentration) or ATP
(10 lM or 100 lM ﬁnal concentration) for 1 h before radiation.
The concentrations and pre-treatment times were determined in
previous experiments. The cells were irradiated with 10 Gy at a
dose rate of 6 MeV/min using a linear accelerator (Siemens,
German), and then returned to the incubator and maintained at
37 C and 5% CO2. The cultured cells were prepared for PCR,
Western blotting, and immunoﬂuorescence analyses. The regimen
of cell irradiation was based on our previous study. We tested the
radiation dose effect from 3, 5, 8 to 10 Gy. We found that inﬂam-
matory mediators did not change at 3 or 5 Gy, but increased signif-
icantly at 8 and 10 Gy. Referring to study that indicated 10 Gy was
the optimal dosage to activate microglia (Hwang et al., 2006), we
applied 10 Gy in the cell irradiation.
2.6. Animals and irradiation
Adult male mice (n = 65; weight, 18–22 g) were randomly
divided into the following groups: non-irradiated controls, irradi-
ated mice, and irradiated mice administered BBG. Mice in the ﬁnal
group received an intraperitoneal injection of BBG (50 mg/kg/day)
2 h before irradiation, for 7 consecutive days. Mice in the control
and irradiation alone groups were injected with the same volume
of saline. Animal irradiation was performed using a 6 MV
b-ionizing-ray linear accelerator (Siemens, Germany). The head of
each mouse was placed in a treatment ﬁeld (2  2 cm2) within
the conﬁnes of the whole-brain from the post-canthus line to the
post-aurem line. A single dose of 30 Gy was given at a dose rate
of 3 Gy/min and a source-to-skin distance of 100 cm. In previous
study, single dose higher than 25 Gy were applied to induce brain
injury in rats (Panagiotakos et al., 2007). Study showed that
microglial-derived COX-2 did not increase if the dose was less than
25 Gy (Olschowka et al., 1997). We therefore used a single dose of
30 Gy for in vivo irradiation. The animals were sacriﬁced 3, 7, and
14 days after irradiation, or were followed for 8 weeks to evaluate
their spatial learning activities. These time points were decided
according to our previous study, showing that the gene and protein
expression alteration occurs as early as 3 days, morphological
change 7 days, while cognition impairment 8 weeks (Peng et al.,
2014). For detection of neurogenesis in the dentate gyrus, bromod-
eoxyuridine (BrdU) (Sigma, USA) at 100 mg/kg i.p. was adminis-
tered started 7 days before sacriﬁced, once daily for 6
consecutive days, and then three times on the day of sacriﬁce
(10 h, 6 h and 2 h prior to sacriﬁce).
2.7. Collection of cerebrospinal ﬂuid from the mouse cisterna magna
Cerebrospinal ﬂuid (CSF) was collected from the mouse cisterna
magna using Liu’s procedure (Liu and Duff, 2008). Brieﬂy, after the
mice were deeply anesthetized, the necks were shaved and the
mice were placed on the stereotaxic instrument. The surgical
equipment was sterilized thrice using 10% povidone iodine and
70% ethanol. The animal’s head was placed at an angle of approx-
imately 135 to the body. A sagittal incision was made inferior to
the occiput, and the subcutaneous tissue and muscles were
separated until the medulla oblongata and CSF space were visible.
A capillary tube was placed into the cisterna magna, and CSF was
collected in a capillary tube. The mice were sutured and placed
in a 37 C incubator for recovery.
2.8. Inhibiting P2X7R expression using short interfering RNAs
Primary microglia in 6-well plates were maintained in
proliferating medium for 2 days. Cells at 30–50% conﬂuence weretransfected with a negative control short interfering RNA (siRNA)
(50-UUCUCCGAACGUGUCACGUTT-30) or a P2X7R-speciﬁc siRNA
(50-CCGUACUCAUCAAGAAUAATT-30), both of which were synthe-
sized by GenePharma (Shanghai, China). Brieﬂy, to prepare the
transfection mixture, Transfectamine (5 ll; Invitrogen) and siRNA
(10 ll) were added individually to Opti-MEM Reduced Serum
Medium (ﬁnal volume of 250 ll) and incubated for 5 min. The
siRNA and Transfectamine solutions were then combined, mixed
by gentle pipetting, and incubated at room temperature for
20 min. Prior to the addition of the transfection mixture, the cells
were washed with Opti-MEM, and then a 1500 ll aliquot of fresh
Opti-MEM was added to each well. The transfection mixture was
added to the cells in a drop-wise manner, and the cells were incu-
bated at 37 C for 20 min. Primary microglia were treated with the
negative control or P2X7R-speciﬁc siRNA for 6 h. Gene and protein
expression levels were detected by real-time PCR andWestern blot
analysis, respectively.
2.9. Quantitative PCR and RT-PCR
Total RNA was isolated from cells using the RNeasy Plus Mini
Kit (TaKaRa), according to the manufacturer’s instructions. After
reverse transcription, quantitative real-time PCR was performed
using primers speciﬁc for the genes encoding P2X7R and inﬂam-
matory mediators IL-6, COX-2, and TNF-a. Fast thermal cycling
was performed using a Real-Time PCR System (Roche LightCycler
480) under the following conditions: denaturation at 95 C for
10 s, followed by 40 cycles of 95 C for 10 s, 60 C for 10 s, and
72 C for 20 s. Semi-quantitative PCR experiments were also per-
formed using primers that speciﬁcally ampliﬁed the C-terminal
region of the full-length transcript encoding the P2X7R. The results
were expressed as the relative mRNA expression of the threshold
cycle value, and were normalized by parallel ampliﬁcation of the
endogenous control GAPDH. The target mRNA expression level in
control group (target mRNA/GAPDH value) was set to 100%, and
the mRNA in other groups were converted to fold changes after
comparing to the control group.
2.10. Western blotting
Total protein (20 lg) was electrophoresed through a 10%
SDS–PAGE gel and transferred to a PVDF membrane. Western
blotting was performed with the following primary antibodies:
polyclonal rabbit anti-P2X7R (1:350), monoclonal rabbit
anti-COX-2 (1:200), and anti-GAPDH (1:500). The ﬁlters were incu-
bated with the primary antibody in 5% dried non-fat milk at 4 C
overnight. A secondary goat anti-rabbit polyclonal antibody
(1:500) was used prior to chemiluminescent detection. An imaging
densitometer scanner controlled by the Quantity One PC software
(Bio-Rad, USA) was used to detect the signals. In all cases, the aver-
age intensity of the pixels in a background-selected region was cal-
culated and subtracted from each pixel in the sample. To correct
for deviation, the densitometry values obtained in the linear range
of detection were normalized to those obtained for GAPDH.
Statistical analysis was performed using a one-way ANOVA,
followed by the Bonferroni correction.
2.11. Immunohistochemistry and immunocytochemistry
After being anesthetized with 10% chloral hydrate (4 ml/kg), the
animals received were perfused with phosphate-buffered saline
(PBS) and then 4% paraformaldehyde. After perfusion, the brains
were removed quickly and post-ﬁxed in 4% paraformaldehyde
overnight. The brains were then dehydrated in a gradient sucrose
solution (10%, 20%, and 30%) at 4 C. Serial sections of mouse brains
(10 lm thickness) were cut using a cryostat. The microscope slides
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tant solution at 30 C until morphological staining. After rinsing
with 0.3% Triton X-100 for 30 min at 37 C, the sections were
blocked in solution containing 5% normal goat serum for 1 h, and
then washed several times. The sections were then incubated with
the following primary antibodies at 4 C overnight: polyclonal
anti-IBA1 (1:400, for microglia of brain section), monoclonal
anti-NeuN (1:300), monoclonal anti-tubulin (1:1000), and
polyclonal rabbit anti-P2X7R (1:200). The primary antibodies were
detected by incubation of the sections with Alexa-488- and
Alexa-594-conjugated secondary antibodies (1:500) at room tem-
perature for 1 h. The sections were cover-slipped with glycerol
and detected using an Olympus BX5 microscope. The percentage
of activated microglial cells was determined for each group. For
each repeated experiment, the numbers of IBA1+ cells were
counted in six random ﬁelds (200 magniﬁcation). Resting micro-
glia exhibited a branch-like form, while activated microglial cells
were characterized by bigger soma and round or amoeboid shapes.
For immunocytochemistry, the cells were washed twice with
PBS, ﬁxed with 4% paraformaldehyde for 20 min, and then blocked
with 5% goat serum albumin for 1 h. The cells were then incubated
with a monoclonal rat anti-CD11b antibody (1:100, for cultured
primary microglia) at 4 C overnight, washed three times with
PBS, incubated with rat anti-rabbit Cy3-conjugated secondary anti-
bodies (1:500) for 1 h in a 37 C thermostat incubator, and then
cover-slipped with anti-ﬂuorescence-quenching reagent (Boshide,
China). After DAPI staining, the ﬂuorescent images were detected
and analyzed as described above. Resting microglia had relatively
small soma with thin protrusions, while activated microglia had
amoeboid shapes with bigger soma and thicker but shorter protru-
sions. For each repeated experiment, the cells were counted in six
random ﬁelds (200 magniﬁcation).
After incubation of cultured neurons with 100 nM ATP for 24 h,
the cells were double stained using a NeuN and TUNEL kit, accord-
ing to the manufacturer’s instructions. The ﬂuorescent imaging
was performed and analyzed as described above.
2.12. ELISA
Primary microglia, astrocytes, and neurons (2  106 in 2 ml of
medium) were seeded into 60 mm dishes and treated as indicated.
The radiation plus BBG or ATP groups were pre-treated with BBG or
ATP for 60 min. The radiation and radiation plus BBG or ATP groups
were exposed to 10 Gy radiation. The supernatants were collected
24 h and 48 h after irradiation and analyzed using an ATP
Fluorometric Assay Kit (BioVision, Cat. No. K354–100), according
to the manufacturer’s instructions. All samples were stored at
80 C until the ELISAs. The standard samples and control groups
were added to the corresponding wells. The biotin-labeled primary
antibody (diluted to 1 lg/ml in blocking buffer) was added to each
well (50 ll/well), and the plate was incubated with agitation at
37 C for 90 min. The plate was then washed four times with wash-
ing buffer, and a secondary HRP-conjugated antibody (diluted in
blocking buffer according to the manufacturer’s instructions) was
added to each well (100 ll/well). Subsequently, the plate was
washed ﬁve times with wash buffer. TMB substrate (100 ll) was
added to each well, and the plate was incubated in the dark at
room temperature for 30 min. Finally, the reaction was stopped
by the addition of stop solution (100 ll/well). The absorbance at
595 nm was determined using a microplate reader, and the data
were analyzed using SoftMax Pro Software.
The ATP levels in CSF samples of participants were measured
using ATPlite 1step kit (PerkinElmer) according to the guideline
protocol. The emitted light, produced by the reaction of ATP with
added luciferase and D-luciferin, is proportional to the concentra-
tion of ATP. In a 96-well black clear-bottom plate, 100 lL of thereconstituted reagent were added to each well containing 2  104 -
cells (100 lL), equilibrated at room temperature. The plate was
shaken for 2 min at 700 rpm using an orbital microplate shaker,
then the luminescence was measured using a multiwell plate
reader (Wallac Victor2, PerkinElmer).
2.13. Morris water maze
Spatial learning and memory were evaluated at 8 weeks
post-irradiation using the Morris water maze, as described previ-
ously (Peng et al., 2014). Mice were trained in the Morris water
maze for 7 days with four trials per day (n = 6 animals per group).
The latency in ﬁnding the platform and the swim path length were
analyzed using a computerized video tracking system (DMS-2).
The probe trial was performed on day 7, during which the mice
were allowed to explore the water maze platform with the
platform removed for 60 s. The time spent in each quadrant and
platform location crossings were recorded for the 60 s probe trial.
After the maze test, the animal was dried with a towel and
returned to its cage located next to an electric radiator.
2.14. Statistics
All experiments were repeated at least three times, and the
results are presented as the mean ± SEM. The statistical signiﬁ-
cance of the differences was analyzed using Student’s t-test
between two groups and One-way ANOVA with Bonferroni’s cor-
rection for multiple group comparison. For analysis of Morris water
Maze, ANOVA with repeated measures (compound by exercise by
days) was used for path length and latency. One-way ANOVA
was applied to analyze the probe trials. Pearson’s correlation coef-
ﬁcient was used for correlation analyses, R > 0.8 reﬂected a high
positive correlation, 0.3 < R < 0.8 reﬂected a moderate positive cor-
relation, and R < 0.3 reﬂected no correlation. P < 0.05 was consid-
ered statistically signiﬁcant.3. Results
3.1. The ATP level in the CSF is positively correlated with the severity of
RBI
The release of ATP from injured cells can trigger cellular injury
(Haag et al., 2007), indicating a possible relationship between eATP
and neuronal damage in RBI. To test this hypothesis, the ATP levels
in CSF samples from patients with (case group) and without (con-
trol group) RBI were compared. We found that the levels of eATP in
CSF of case group were higher than those of control group (Fig. 1A).
There was a positive correlation between the concentration of
eATP and the SOMA score (R = 0.883, P < 0.001), the brain edema
volume (R = 0.906, P < 0.001), and the necrosis volume (R = 0.738,
P < 0.001), suggesting that elevated levels of eATP are associated
with aggravated symptoms of RBI (Fig. 1B). Moreover, the levels
of inﬂammatory mediators (COX-2, IL-6, and TNF-a) were also
increased in the case group than in the control group (Fig. 1C),
and these upregulated levels were positively correlated with the
elevated eATP levels (Fig. 1D; RCOX-2 = 0.938, RIL-6 = 0.845,
RTNF-a = 0.902 and all P < 0.001).
Next, we used a mouse model of RBI in which mice undergoing
whole brain irradiation with a single dose of 30 Gy and measured
the levels of eATP in the CSF of RBI mice. At 3 and 7 days
post-irradiation, the eATP levels in the CSF of the irradiated mice
were signiﬁcantly higher than those in the control mice (Fig. 1E).
To further conﬁrm that ATP is released by irradiation-induced cell
damage, we exposed primary microglia, astrocytes, and neurons to
a single 10 Gy dose of radiation. Consistently, we found an
Fig. 1. Increased extracellular ATP (eATP) related to severity of radiation-induced brain injury (RBI). (A, C) Concentrations of ATP, COX-2, IL-6 and TNF-a in CSF of RBI patients
(case group) and control people (control group), mean ± SEM (ATP: t(35.075) = 10.310, P < 0.001; COX-2: t(89) = 2.120, P = 0.037; IL-6: t(38.514) = 10.091, P < 0.001; TNF-a:
t(47.293) = 4.729, P < 0.001. Student’s t-test); *P < 0.05 versus control group, ***P < 0.001 versus control group. (B) The SOMA score, edema and necrotic volume showed a
positive correlation with eATP level. (D) The eATP level of case group showed a highly positive correlation with COX-2, IL-6 and TNF-a respectively. (E) In irradiated mice, the
ATP levels in CSF at 3 and 7 days post-irradiation were shown as mean ± SEM; n = 10 (F(2,27) = 209.297, P < 0.001, ANOVA); **P < 0.01 versus Ctrl, ***P < 0.001 versus Ctrl. (F)
ATP levels in primary microglia, astrocytes and neurons at 24 and 48 h after radiation were shown as mean ± SEM; n = 4 (Microglia: F(2,9) = 264.670, P < 0.001, ANOVA.
Astrocytes: F(2,9) = 714.937, P < 0.001, ANOVA. Neurons: F(2,9) = 833.664, P < 0.001, ANOVA); *P < 0.05 versus Ctrl, **P < 0.01 versus Ctrl.
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(Fig. 1F). These data indicate that neurons and glial cells release
ATP when damaged by radiation, and that elevated eATP is posi-
tively related to the severity of RBI.
3.2. ATP enhances microglial activity following radiation and ampliﬁes
the inﬂammatory response
Next, we examined whether the elevated eATP in RBI are
merely a secondary response to radiation injury or an initiator that
enhances microglial activity. Microglia were treated with radia-
tion, ATP, or radiation plus ATP. Morphological changes were
noted, and the percentages of activated microglia were quantiﬁed
by CD11b staining. Resting microglia in control group had rela-
tively small soma with thin protrusions; by contrast, microgliaexposed to irradiation or exogenous ATP were activated with big-
ger soma, thicker but shorter protrusions and amoeboid morphol-
ogy (Fig. 2A). Quantiﬁcation of the activated microglia indicated
that exposure to both radiation and ATP had an additive effect on
microglial activation (Fig. 2B).
Next, the production of microglial inﬂammatory mediators in
response to radiation and/or ATP was determined using ELISAs.
We found that 10 lM ATP did not induce the release of all these
inﬂammatory mediators. However, the combination of irradiation
and 100 lM ATP caused a signiﬁcant higher level of release of
the inﬂammatory mediators than either treatment alone, indicat-
ing that ATP enhances the response of microglia to radiation stim-
ulation and ampliﬁes the release of inﬂammatory mediators such
as COX-2, IL-6, and TNF-a (Fig. 2C). To determine whether ATP
exacerbates neuronal injury after irradiation by activating
Fig. 2. ATP enhances microglial activity towards radiation and ampliﬁes the inﬂammatory response. (A) Primary microglia were exposed to 10 Gy of radiation, then
immunostained with CD11b antibody 24 h later. Representative images under indicated treatments were shown. Scale bar, 50 lm. (B) Statistical data of activated microglia
were shown as mean ± SEM; n = 6 (F(3,20) = 218.323, P < 0.001, ANOVA); ⁄, compared to control group, P < 0.05; #, compared to either ATP or radiation treated group, P < 0.05.
(C) ELISA assays showed the alteration of inﬂammatory mediators in the supernatant of primary microglia at 24 h and 48 h under the treatment of ATP at 10 lM and 100 lM.
Mean ± SEM; n = 3 (treatment of ATP at 10 lM, COX-2: F(5,12) = 178.128, P < 0.001; IL-6: F(5,12) = 49.663, P < 0.001; TNF-a: F(5,12) = 180.759, P < 0.001. Treatment of ATP at
100 lM, COX-2: F(5,12) = 247.456, P < 0.001; IL-6: F(5,12) = 183.961, P < 0.001; TNF-a: F(5,12) = 412.903, P < 0.001. ANOVA); *P < 0.05, versus control group; a, versus ATP
group, P < 0.05; b, versus radiation group, P < 0.05; c, versus radiation 48 h group, P < 0.05. (D) Neurons were co-cultured with control micorglia, irradiated microglia, 100 lM
ATP or irradiated microglia treated with ATP. Neurons were then immunostained with NeuN antibody and apoptotic neurons were recognized through TUNEL staining.
Representative images were shown. Scale bar, 50 lm. (E) The ratio of apoptotic neurons to live neurons (apoptotic ratio) was shown as mean ± SEM; n = 6 (F(3,20) = 191.693,
P < 0.001, ANOVA); *P < 0.05, versus control group; #, compared to either ATP or radiation treated group, P < 0.05.
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were co-cultured with primary hippocampal neurons in a tran-
swell system. Apoptotic neuronal cells were detected by double
staining with NeuN and TUNEL. We found that the apoptosis ratio
of neurons co-cultured with microglia exposed to both radiation
and ATP was higher than that of neurons incubated with microglia
that were irradiated or treated with ATP alone (Fig. 2D and E).
These data indicate that irradiation induces direct injury of
neurons and glial cells, leading to the release of ATP, which in turn
enhances microglial activation, ampliﬁes the production of inﬂam-
matory mediators, and aggravates radiation-induced neuronal
injury.
3.3. Blockade of ATP–P2X7R mediated signaling reduces RBI
ATP activates purinergic receptors, including the seven P2XRs
(P2X1-7R). To determine which of these receptors are involved in
RBI, their mRNA expression levels were determined. The mRNAs
encoding the P2X1R, P2X3R, P2X4R, and P2X7R were identiﬁed in
both the control and radiation groups. We found that the levels
of the mRNAs encoding P2X3R and P2X7R were upregulated signif-
icantly after irradiation, and the level of the mRNA encoding P2X7R
was higher than that of the mRNA encoding P2X3R
(Supplementary Fig. 1).
Considering the critical role of P2X7R in various brain injury
(Skaper et al., 2006; Sperlagh and Illes, 2014), we hypothesized
that the increased levels of ATP that occur after exposure to radia-
tion might exacerbate brain injury through the P2X7R mediated
signaling pathway. To conﬁrm this hypothesis, we inhibited the
P2X7R with BBG, a speciﬁc antagonist with low toxicity and
high selectivity that can cross the blood–brain barrier
(Diaz-Hernandez et al., 2009; Peng et al., 2009). Upon exposure
to radiation, the level of P2X7R staining increased accompanied
by change in morphology of the cells to amoeboid phenotype.
Incubation of the cells with BBG (1 lM) prior to irradiation atten-
uated the increased P2X7R expression and morphological transfor-
mations signiﬁcantly, indicating the inhibition of microglial
activation (Fig. 3B).
Our previous study found that neuronal progenitor cells, which
contribute to tissue repair by promoting neurogenesis, were
depleted after RBI, and their differentiation into neurons was
inhibited via microglia-mediated inﬂammatory mechanisms
(Peng et al., 2014). Using a similar methodology, we evaluate the
role of the ATP–P2X7R mediated signaling during RBI in vivo.
Neuronal numbers in the cortex and neuronal proliferation in the
dentate gyrus were evaluated in mice following 14 days of whole
brain irradiation. Beta-tubulin staining revealed that the number
of neurons in the cortex was reduced after irradiation
(Fig. 3C and D). Moreover, the number of BrdU+/NeuN+ cells in
the dentate gyrus was also reduced signiﬁcantly after irradiation
(Fig. 3E and F). Administration of BBG attenuated the
irradiation-induced losses of neurons in the cortex and
BrdU+/NeuN+ neural progenitor cells in the dentate gyrus
(Fig. 3C–F). These results demonstrate that exposure to radiation
induces neuronal injury and decreases neuronal proliferation by
activating microglia through the ATP–P2X7R pathway.
To evaluate the contribution of the ATP–P2X7R mediated sig-
naling in causing neurological deﬁcits in RBI, the spatial learning
and memory of mice were determined at 8 weeks
post-irradiation using a Morris water maze. Consistent with previ-
ous studies (Ben Abdallah et al., 2013; Peng et al., 2014), the
latency and path length to ﬁnd a hidden platform were longer in
irradiated mice than in control mice (Fig. 3G and H). The latencies
and path lengths of irrradiated mice treated with BBG were signif-
icantly shorter than those of mice exposed to radiation alone, but
longer than those of control mice. On day 7 of the experiment,BBG-treated mice spent signiﬁcantly more time in the target quad-
rant of the water maze than irradiated mice (P < 0.05), suggesting
an improved spatial memory (Fig. 3I and J). These data indicate
that inhibition of the ATP–P2X7R mediated signaling can improve
spatial memory and reduce neurological deﬁcits caused by RBI.
3.4. Radiation-induced microglial paracrine signaling is mediated by
P2X7R in vitro
Next, we examined the mechanisms underlying the ATP–P2X7R
mediated signaling pathway in RBI. We ﬁrst tested whether inhibi-
tion of the P2X7R would suppress radiation-induced production of
inﬂammation mediators. Indeed, BBG inhibited the upregulation of
mRNA expression levels COX-2, IL-6, and TNF-a after exposure of
primary microglia to radiation (Fig. 4A). In addition, we found that
the mRNA level of P2X7R was also upregulated in response to irra-
diation, and this upregulation was attenuated by BBG at both the
24 h and 48 h time points (Fig. 4B). These results indicate that
the P2X7R not only mediates radiation-induced activation of
microglia, but also regulates the secretion of inﬂammatory media-
tors. Consistently, our Western blot results further conﬁrmed that
radiation signiﬁcantly upregulated the protein expressions of both
P2X7R and COX-2 (Fig. 4C). Together, these results indicate a speci-
ﬁc role of the P2X7R in microglial activation and secretion of
inﬂammatory mediators induced by radiation.
To exclude any unknown side effects of pharmacological inhibi-
tors, we used the P2X7R knockdown via RNA interference. We
found that upregulation of P2X7R mRNA was inhibited signiﬁ-
cantly by transfection of the microglia with a P2X7R-speciﬁc
siRNA at 24 h or 48 h after irradiation (Fig. 5A). Moreover,
irradiation-induced upregulation of COX-2, IL-6 and TNF-a were
also markedly suppressed at 48 h time point (Fig. 5B).
Consistently, Western blots showed P2X7R and COX-2 protein
were upregulated after radiation and were then inhibited by
P2X7R knockdown at various time point (Fig. 5C, upper panel).
Taken together, these data provide crucial evidence that the
P2X7R is involved in microglial paracrine signaling after radiation,
indicating a feedback loop in microglial activation during RBI.
3.5. Radiation-induced microglial paracrine signaling is mediated by
P2X7R in vivo
Next, we examined the role of the P2X7R in microglial activa-
tion and paracrine signaling in vivo. We found that the colocalized
immune-expressions of IBA-1, a marker for microglia and P2X7R
were remarkably upregulated in irradiated mice (Fig. 6A and B).
Treatment with BBG signiﬁcantly decreased the number of acti-
vated IBA1+ microglia. Irradiation also induced a time-dependent
elevation in the mRNA expression levels of P2X7R (Fig. 6C) and
proinﬂammatory mediators (Fig. 6D). BBG could suppress these
upregulation mainly at 7 days after irradiation (Fig. 6C and D).
Consistently, radiation markedly augmented the protein expres-
sion of P2X7R and COX-2, which could be inhibited by BBG 7 days
after treatment (Fig. 6E). These results conﬁrm that the P2X7R is
involved in activation and paracrine signaling of irradiated micro-
glia in vivo, suggesting that the P2X7R mediates the
radiation-induced release of proinﬂammatory mediators, including
COX-2, IL-6, and TNF-a, in vivo.
3.6. Pathways involved in P2X7R-mediated microglial activation and
paracrine signaling in RBI
To explore the possible mechanisms involved in the
P2X7R-mediated microglial activation and paracrine signaling in
RBI, the nuclear factor jB (NF-jB) and PI3K/AKT transduction
pathways in the diverse cascades of inﬂammation were examined.
Fig. 3. P2X7R is involved in RBI both in vitro and in vivo. (A) Primary microglia exposed to single dose of radiation (10 Gy), or pre-treated with BBG (1 lM) for 1 h before
radiation. Cells were immunostained with P2X7R antibody (green). Representative images were shown (scale bar is 50 lm). (B) Statistical percentages of activated microglia
were shown as mean ± SEM: n = 6 (F(2,15) = 414.764, P < 0.001, ANOVA). (C) Representative sections from cortex immunostained with anti-beta tubulin (red) and Hoechst
33258 (blue). Scale bar is 20 lm. (D) Quantiﬁcation of viable neurons in layer-3 cortex were shown as mean ± SEM; n = 5 (F(2,12) = 85.521, P < 0.001, ANOVA). (E)
Representative sections from hippocampus immunostained with anti-NeuN (green) and anti-BrdU (red) antibodies. Scale bar is 50 lm. Statistical data were shown in (F).
Quantitative analysis showed decreased numbers of BrdU+/NeuN+ NPCs 14 days after irradiation and a restoration using BBG. Data were shown as mean ± SEM; n = 5
(F(2,12) = 171.068, P < 0.001, ANOVA). (G) The swim path and (H) the latency length before arrival on the platform were recorded for 7 consecutive days in each group. (I)
Percentage of time in the northwest quadrant of the water maze for mice in each group. The difference between different groups was assessed using probe trials on day 7 of
training and was analyzed using a 1-way ANOVA followed by Bonferroni’s test, n = 6 (F(2,15) = 127.081, P < 0.001, ANOVA). (J) Swimming trail of each group in probe trial was
recorded by DMS-2. *P < 0.05, versus control group; #, versus radiation group, P < 0.05. (For interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
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Fig. 4. Pharmacological inhibition of P2X7R suppresses radiation induced microglial paracrine signaling. Quantitive real-time PCRs of COX-2, IL-6, TNF-a (A) and P2X7R (B) in
primary microglial cells were performed at 24 h or 48 h post irradiation in indicated groups. Data from control group were set to 100% for normalization. Statistical data were
shown as the mean ± SEM; n = 3 (COX-2: F24h(2,6) = 12.885, P = 0.007; F48h(2,6) = 122.267, P < 0.001. IL-6: F24h(2,6) = 19.116, P = 0.002; F48h(2,6) = 140.384, P < 0.001. TNF-a:
F24h(2,6) = 10.086, P = 0.012; F48h(2,6) = 52.530, P < 0.001. P2X7R: F24h(2,6) = 19.040, P = 0.003; F48h(2,6) = 62.029, P < 0.001. ANOVA). (C) Cells lysates with the same
treatments as in (A) were subjected to Western blot for P2X7R and COX-2. Representative blots of three independent experiments were shown on the left panel, and the
densitometric analysis were shown on the right panel. Mean ± SEM; n = 3 (P2X7R: F24h(2,6) = 3.284, P = 0.109; F48h(2,6) = 38.913, P < 0.001. COX-2: F24h(2,6) = 2.188,
P = 0.193; F48h(2,6) = 56.210, P < 0.001. ANOVA). ⁄, Compared to control group, P < 0.05; ⁄⁄, compared to control group, P < 0.01; ⁄⁄⁄, compared to control group, P < 0.001; #,
compared to radiation treated group, P < 0.05.
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after irradiation of primary microglia, and this effect was inhibited
by BBG pre-incubation (Fig. 7A). The same trend was also observed
for the expression levels of COX-2 and the P2X7R. To test whether
NF-jB is the upstream for COX-2 expression, a NF-jB pathway
speciﬁc inhibitor pyrrolidine dithiocarbamate (PDTC) was used
(Liu et al., 1999). While PDTC had no effect on the expression level
of the P2X7R, it signiﬁcantly reversed the irradiation-induced
COX-2 upregulation and phosphorylated P65. These ﬁndings
indicate that P2X7R activation induces the NF-jB transduction
pathway which is required for COX-2 production after irradiation.
Next, we determined whether the PI3K/AKT pathway is engaged
in radiation-induced microglial paracrine signaling. We found that
the expression level of p-AKT was upregulated after irradiation and
attenuated by BBG pre-incubation (Fig. 7B). LY294002, a speciﬁc
inhibitor of PI3K (Liu et al., 2010), had an inhibitory effect on the
radiation-induced enhancements of p-AKT and COX-2, but had
no effect on the expression level of the P2X7R (Fig. 7B). These
results suggest that the PI3K/AKT transduction pathway
participates in the paracrine signaling of microglia activated by
radiation, and that the P2X7R is an upstream activator of this
pathway. Overall, the data indicate that both the NF-jB and
PI3K/AKT signaling pathways are involved in the activation and
paracrine signaling of irradiated microglia after P2X7 receptor
activation.4. Discussion
Communication between microglia and neurons in many
pathological cascades involves eATP (Ekdahl et al., 2009). Here,
we report that elevated eATP is positively related to the severity
of RBI and the levels of inﬂammatory mediators (COX-2, IL-6, and
TNF-a) in CSF of patients. We also show that radiation-induced
the release of ATP from cultured neuronal/glial cells and also in
the CSF of irradiated mice. The elevated eATP activates P2X7 recep-
tor to enhance microglial activity and ampliﬁes the production of
inﬂammatory mediators, leading to aggravation of neuronal injury.
Pharmacological or genetic blockade of the P2X7R suppressed the
radiation-induced secretion of inﬂammatory mediators by micro-
glia, promoted cell proliferation in the dentate gyrus, and
improved the spatial learning of irradiated mice. Finally we found
that the NF-jB and PI3K/AKT signaling pathways are critical for
P2X7R-dependent microglial activation and the subsequent pro-
duction of inﬂammatory mediators. These data demonstrate that
the ATP–P2X7R axis is engaged in a self-perpetuating neurotoxicity
cycle between microglia and neurons, and thus contributes to the
pathogenesis of radiation encephalopathy (Fig. 8). In this vicious
cycle, neuronal cells injured by ionizing radiation release ATP,
which triggers microglia to produce inﬂammatory mediators
which further exacerbates the neuronal injury and other patho-
physiologic processes. Therefore, blockade of P2X7R by the speciﬁc
Fig. 5. Genetic knockdown of P2X7R suppresses radiation induced microglial paracrine signaling. Cells treatment as in Fig. 4 were transfected with P2X7R siRNA fragments.
Real-time PCRs were performed to detect the mRNA levels of P2X7R (A), COX-2, IL-6 and TNF-a (B). Mean ± SEM; n = 3 (P2X7R: F24h(2,6) = 162.071, P < 0.001;
F48h(2,6) = 113.515, P < 0.001. COX-2: F24h(2,6) = 2.624, P = 0.152; F48h(2,6) = 146.905, P < 0.001. IL-6: F24h(2,6) = 5.088, P = 0.051; F48h(2,6) = 215.095, P < 0.001. TNF-a:
F24h(2,6) = 21.584, P = 0.002; F48h(2,6) = 137.090, P < 0.001. ANOVA). (C) Primary microglia treated as in (A) were subjected to Western blot. The protein expression levels of
P2X7R and COX-2 were shown on the upper panel and the densitometric analysis on the bottom. Mean ± SEM; n = 3 (P2X7R: F24h(2,6) = 274.422, P < 0.001; F48h(2,6) = 80.972,
P < 0.001 .COX-2: F24h(2,6) = 21.157, P = 0.002; F48h(2,6) = 75.182, P < 0.001. ANOVA). ⁄, Compared to control group, P < 0.05; ⁄⁄, compared to control group, P < 0.01; ⁄⁄⁄,
compared to control group, P < 0.001; #, compared to radiation treated group, P < 0.05; ##, compared to radiation treated group, P < 0.01.
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our knowledge, this is the ﬁrst study to investigate the underling
mechanism of P2X7R involvement in RBI, and the potential thera-
peutic effect of BBG targeting P2X7R.
P2X7R, as an ionotropic P2 receptor, is implicated in several CNS
disorders, such as lipopolysaccharide-induced inﬂammatory
responses (Bernardino et al., 2008), neuronal damage in the rat
striatum (Carmo et al., 2014), amyotrophic lateral sclerosis
(Gandelman et al., 2010), Alzheimer’s disease (Lee et al., 2011),
spinal cord injury (Peng et al., 2009; Wang et al., 2004) and stroke
(Lammer et al., 2011). These studies indicate that microglial P2X7R
is a master hub for microglia activation and neuroinﬂammation,
indicating P2X7R to be a potent therapeutic target for various neu-
rological diseases (Skaper et al., 2006; Sperlagh and Illes, 2014).
OxATP and PPADS, two ﬁrstly reported P2X7R antagonists, were
reported to be neuroprotective (Wang et al., 2004). However,oxATP and PPADS are nonselective, and their actions cannot be
reliably attributed to P2X7R blockade. Then BBG, an analog of
FD&C blue dye, a more selective antagonist of P2X7R was found
to reduce neuronal injury (Cotrina and Nedergaard, 2009; Jiang
et al., 2000; Peng et al., 2009). Studies showed that BBG suppresses
the inﬂammatory response mediated by P2X7R and inhibits down-
stream events such as membrane blebbing and endocytosis of the
cationic dye YOPRO-1 (Jiang et al., 2000). Consistently, blockade of
P2X7R by BBG prevented ATP excitotoxicity in mice (Matute et al.,
2007; Sharp et al., 2008). In addition, BBG has been shown to
improve the functional and histopathological consequences of
spinal cord injury in rat models (Peng et al., 2009; Wang et al.,
2004). However, Alexander and colleagues failed to repeat these
results when trying to assess the consideration of clinical testing
using selective P2X7R antagonists (Marcillo et al., 2012). Since
the dosing schedule of BBG in the spinal cord injury model of
Fig. 6. P2X7R is involved in radiation induced microglia activation in vivo. (A) Mice were treated as mentioned in the material and methods section. Double-
immunoﬂuorescence staining of the cortex with IBA1 for microglia (green) and P2X7R (red) were shown (scale bar 20 lm). (B) Statistical percentage of P2X7R colocalized
with IBA1 were shown as mean ± SEM; n = 6 (F(2,15) = 1554.729, P < 0.001, ANOVA). mRNA levels of P2X7R (C) and COX-2, IL-6 and TNF-a (D) of the whole brain lysates from
irradiated mice were shown by using the real-time PCR assays. GAPDH was used as an internal control. Mean ± SEM; n = 3 (P2X7R: F3d(2,6) = 108.085, P < 0.001;
F7d(2,6) = 55.677, P < 0.001. COX-2: F3d(2,6) = 66.883, P < 0.001; F7d(2,6) = 650.170, P < 0.001. IL-6: F3d(2,6) = 33.269, P = 0.001; F7d(2,6) = 329.607, P < 0.001. TNF-a:
F3d(2,6) = 64.045, P < 0.001; F7d(2,6) = 46.800, P < 0.001. ANOVA). (E) Mice were treated with or without BBG administration for 3 or 7 days post-irradiation. Then the
brain lysates were subjected to Western blot assays to show the protein alteration of P2X7R and COX-2. The bar graph showed the statistical results of Western blots.
Mean ± SEM; n = 3 (P2X7R: F3d(2,6) = 13.193, P = 0.006; F7d(2,6) = 39.367, P < 0.001. COX-2: F3d(2,6) = 50.477, P < 0.001; F7d(2,6) = 13.290, P = 0.006. ANOVA). ⁄, Compared to
control group, P < 0.05; ⁄⁄, compared to control group, P < 0.01; ⁄⁄⁄, compared to control group, P < 0.001; #, compared to radiation treated group. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 7. NF-jB and PI3K/AKT pathways are involved in microglial activation and paracrine signaling in RBI. (A) Primary microglia pretreated with BBG (1 lM) or PDTC for
60 min were exposed to radiation at 10 Gy. Protein expressions of P-P65, P65, P2X7R and COX-2 were determined by Western blots. The expression of GAPDH was served as
an internal control. The statistical data of each protein versus GAPDH were shown on the right panel as mean ± SEM; n = 3 (P2X7R: F(3,8) = 89.387, P < 0.001; P-P65:
F(3,8) = 72.480, P < 0.001; P65: F(3,8) = 0.715, P = 0.570; COX-2: F(3,8) = 141.643, P < 0.001. ANOVA). (B). Cells lysates were subjected to Western blots with anti-p-AKT, AKT,
P2X7R and COX-2 antibodies. The expression of GAPDH was served as an internal control. The statistical data were shown as mean ± SEM; n = 3 (P2X7R: F(3,8) = 199.603,
P < 0.001; P-AKT: F(3,8) = 569.204, P < 0.001; AKT: F(3,8) = 1.149, P = 0.387; COX-2: F(3,8) = 210.079, P < 0.001. ANOVA). ⁄, Compared to control group, P < 0.05; #, compared to
radiation treated group, P < 0.05.
Fig. 8. Schematic representation of neurotoxicity cycle mediated by ATP and P2X7R in RBI. Injured neurons under radiation release large amount of extracellular ATP (eATP).
eATP, through P2X7R, further activates microglia and induces the release of inﬂammatory mediators such as COX-2, IL-6 and TNF-a, which exacerbates neuronal injury and
other pathophysiologic process. Pharmacological or genetic inhibition of ATP-P2X7 axis restores neuronal cell proliferation and alleviate RBI.
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after injury and once daily on days 2 and 3), a longer duration of
dosing is recommended to achieve a robust effect. In addition, this
divergence implies that the potentially exciting therapies requirefurther preclinical investigations before the implementation in
human clinical trials targeting P2X7 receptors. In our current
study, the BBG scheme was relatively long (50 mg/kg, started
before radiation and continued once daily for seven consecutive
P. Xu et al. / Brain, Behavior, and Immunity 50 (2015) 87–100 99days). In line with the neuroprotective potential of BBG, we found
that BBG inhibits microglial activation and paracrine signaling,
thereby alleviating radiation encephalopathy.
Study showed that P2X7R channel allows Ca2+ inﬂux and K+
outﬂow when activated by ATP. The elevation of Ca2+ through
P2X7R is important for NF-jB and PI3K/AKT transduction path-
ways (Potucek et al., 2006). Kaya and colleague reported that ATP
selectively suppresses the synthesis of the inﬂammatory protein
MRF-1 through Ca2+ inﬂux via P2X7R in cultured microglia (Kaya
et al., 2002). Indeed, we found that inhibition of P2X7R inactivated
NF-jB and PI3K/AKT cascade associated with RBI. But, how the
P2X7R-mediated Ca2+ inﬂux and K+ outﬂow regulates the internal
molecular functions under RBI remains obscure, and is worthy of
further investigation.
Despite the optimistic efﬁcacy of P2X7 antagonists in
pre-clinical studies, it has yet to be determined whether these
P2X7 antagonists will translate into positive clinical outcomes.
The pioneering developments of P2X7R antagonists, such as
CE-224,535 (Stock et al., 2012) and AZD-9056 (Keystone et al.,
2012) have been entered Phase II trials in rheumatoid arthritis
patients. Considering the acceptable safety and tolerability proﬁle
of these antagonists, it is possible to develop P2X7R-targeting com-
pounds in CNS disorders. The absence or low expression of P2X7Rs
in healthy tissue limits systemic side effects of these compounds
and although the majority of known antagonists fails to pass the
blood–brain barrier, BBG and some new antagonists readily enter
the CNS (Bhattacharya et al., 2013). Thus, modulators of P2X7R
may become important therapeutic tools (Sperlagh and Illes, 2014).
In conclusion, our study describes the relevance of
eATP-induced microglial activation and release of inﬂammatory
mediators during RBI. The mechanisms involve the activation of
the P2X7R, NF-jB and PI3K/AKT signaling pathways in microglia,
initiation of a secondary inﬂammatory response and subsequently
leading to neuronal damage. These ﬁndings have signiﬁcant clini-
cal implications for the treatment of RBI; speciﬁcally, blockade of
P2X7R breaks the neurotoxic cycle between neurons and microglia,
thereby diminishing excessive brain injury and improving out-
comes after radiation.
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